News
Dogwood Therapeutics doses first fifty patients in ongoing Halneuron phase 2b CINP clinical trials: Atlanta Saturday, August 9, 2025, 18:00 Hrs [IST] Dogwood Therapeutics Inc, a d ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback